Roche won another reprieve in its fight againstthousands of Accutane safety claims. The drugmaker persuaded a New Jersey appeals court to overturn an $18M jury…

With the vast majority of drugs and drug ingredients being manufactured outside the U.S., the FDA has had to step up its international oversight and often ban…

Bristol-Myers Squibb’s immunotherapy Opdivo has been powering ahead, racking up sales and new FDA approvals one after another. And with cancer-fighting…

The sun is finally shining on drug company payments to doctors in Europe, and payment information has begun to trickle out.

What’s in a new name? For a Takeda and Lundbeck antidepressant, new marketing work.

Tenet Partners is out with its ninth annual evaluation of the most powerful brands, and a pair of pharmas locked up top spots on the list.

Failings at an Indian CRO have tripped up Novartis and Teva as the European Medicines Agency said today that it would suspend some approved generics from the…

Pharma, already smarting in Japan from new price controls imposed by the government, may now face additional limits on new breakthrough drugs. Up first for…

Back when it was fending off Pfizer’s hostile takeover attempt, AstraZeneca found support from some officials in the U.K. who blasted the deal on its potential…